Fungus - Medical Overview Flashcards
MYCOSES Classification
MYCOSES – Systemic mycoses caused by pathogenic fungi • Histoplasmosis • Blastomycosis • Coccidioidomycosis • Paracoccidioidomycosis – Systemic mycoses caused by opportunistic fungi • Pneumocys pneumonia • Candidiasis • Aspergillosis • Cryptococcosis • Zygomycosis – Superficial, cutaneous and subcutaneous mycoses • Dermatophytoses • Malassezia • Chromoblastomycosis • Phaeohyphomycosis • Mycetomas • Sporotrichosis
Medical Mycology
- Most mycoses are amont the most difficult diseases to diagnose and treat
+ Sign of mycoses are often missed or misinterpreted
+ Antifungal agents are toxic to humans
Epidemiology of Mycoses
- Everywhere in the environment
- Via inhalation, trauma or ingestion
- Most mycoses are NOT CONTAGIOUS
+ FDermatophytes are the major exception and are transmitted via formites
+ Some species of Candida and Pneumocystis can be transmitted by contact
Epidemics due to mass exposure to environmental source of fungi
Clinical Manifestations
3 Categories
- Fungal Infections
+ Most common mycoses
+ Caused by presence of true pathogens or opportunists
- Toxicoses
+ Acquired through ingestion
+ Occur when poisonous mushrooms are eaten
- Allergies
+ Most often result from the inhalation of fungal spores
Diagnosis of Fungal Infections
1- Patient history
2- Moprhological analysis of the fungus involved::
- Sabouraud Dextrose agar used to culture fungi
3) Various Techniques to detect fungal cells in patient specimens
- Potassium hydroxide preparation (BLUE)
- Gomori methenamine silver stain
- Direct immunoflourescence (GREEN)
4) Opportunistic infections are especially challenging
5) Symptoms and imaging resembles tuberculosis or cancer
Antifungal Therapies
1) Most difficult to heal
- resistant towards T cell-Mediated immune responses
- Biochemically similar to human cells
+ Ergosteril is often the target
2) Amphotericin B
- GOld standard of antigungals
- One of the more toxic antifunga agents
3) Azole drugs:
- Less toxic alternatives drugs
- Ketoconazole, Itraconazolre and Fluconazole
4) Non Ergosteroll antfungal drugs:
- Griseofulvin
+Interferes with microtubule formation and mitosis.
+ Accumulates on the outer layers of hte skin, not toxic, 1year
- 5-fluorocytosine
+ Nucleoside analog, inhibits DNA and RNA synthesis
- Echinocandins
+ Inhibits the synthesis of glucan that makes up part of the fungal cell wall : Osmotic lysis
5) Opprotunistic infections require 2-step treatment
- High dose treatment to reduce pathogens
- Low Dose Maintenace therapy (life long)
- resistance is a rare event
Antifungal Vaccines
1) Difficult to develop
- fungal metabolism similar to our own
2) Developed vaccines againsts:
- Coccidioides
- Blastomycosis
- Candida
Antifungal Therapies
Amphotericin B
Amphotericin B
- GOld standard of antigungals
- One of the more toxic antifunga agents
Antifungal Therapies
Azole drugs:
Azole drugs:
- Less toxic alternatives drugs
- Ketoconazole, Itraconazolre and Fluconazole
Antifungal Therapies
Non Ergosteroll antfungal drugs
Non Ergosteroll antfungal drugs:
- Griseofulvin
+Interferes with microtubule formation and mitosis.
+ Accumulates on the outer layers of hte skin, not toxic, 1year
- 5-fluorocytosine
+ Nucleoside analog, inhibits DNA and RNA synthesis
- Echinocandins
+ Inhibits the synthesis of glucan that makes up part of the fungal cell wall : Osmotic lysis
Opprotunistic infections require 2-step treatment
Opprotunistic infections require 2-step treatment
- High dose treatment to reduce pathogens
- Low Dose Maintenace therapy (life long)
- resistance is a rare event